Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Första-i-mänsklig integrerad endoskopisk ultraljud (EUS) Navigationssystem Klinisk studie (EZ-EUS1)

16 november 2026 uppdaterad av: IHU Strasbourg

The complexity of the medical expertise required for endoscopic manipulation and image interpretation complicates the implementation of echo-endoscopy (or EUS for "Endoscopic Ultrasound").

The "EZ-EUS" system is designed to help the operator understand the orientation and the position of the probe tip in the patient. This system offers navigation similar to that of the Global Positioning System (GPS), but for EUS procedures. To achieve this, it uses a 3D model based on scanner imaging data recorded before the procedure.

In this study, the intended purpose of the "EZ-EUS" system is to help echo-endoscopy operators to easily identify and assess the pancreatic gland, and to facilitate the detection of any lesions.

The hypothesis is that, thanks to this tool, procedure times will be shortened, and the pancreas and its lesions will be fully imaged to facilitate their localization and characterization.

Studieöversikt

Status

Avslutad

Detaljerad beskrivning

Since its inception in the 1980s, the field of endoscopic ultrasound (EUS) has experienced significant expansion and evolution and is now a pivotal component of pancreatobiliary assessment. Proficiency in EUS necessitates a synthesis of cognitive and technical competencies encompassing endoscopic manipulation, image interpretation, and an extensive comprehension of intraabdominal anatomical structures. Acquisition of these competencies is a progressive and highly operator-dependent process, and thereby necessitates an extended learning curve for practitioners.

The American Society for Gastrointestinal Endoscopy (ASGE) has recommended the performance of a minimum of 190 supervised EUS for practicing autonomous EUS. However, the compliance of these parameters does not guarantee competence achievement, and there is a wide variability between endoscopists leading to disparities in the techniques' quality and irregular outcomes.

The "EZ-EUS" system is designed to help the operator understand the orientation and the position of the probe tip in the patient. This system offers navigation similar to that of the Global Positioning System (GPS), but for EUS procedures. To achieve this, it uses a 3D model based on scanner imaging data recorded before the procedure.

In this study, the intended purpose of the "EZ-EUS" system is to assist echo-endoscopy operators in accurately locating the pancreatic gland, conducting a comprehensive evaluation of the region of interest, and facilitating the detection and identification of lesions within it. We hypothesize that this tool will streamline procedure times and enable comprehensive imaging of the pancreas and its lesions, thereby reducing the need for expert guidance for trainees and shortening the EUS learning curve. This study is exploratory, prospective, monocentric and will compare two randomized groups (with and without the EZ-EUS navigation system).

Studietyp

Interventionell

Inskrivning (Faktisk)

11

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Strasbourg, Frankrike, 67000
        • Hôpitaux Universitaires de Strasbourg

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Man or woman over the age of 18 years old.
  • Patient having a EUS procedure for pancreas study planned within the frame of his or her clinical care.
  • Patient whom pre-operative imaging indicates one lesion, a suspicion of lesion, chronic pancreatitis or fatty pancreas.
  • Patient with a good definition on the CT scan done within the year to the EUS.
  • Patient able to receive and understand information related to the study and give his or her written consent.
  • Patient affiliated to the French social security system.

Exclusion Criteria:

  • Patient with altered anatomy of the upper digestive tract due to previous surgery.
  • Patient with known abnormal anatomy of the upper digestive tract.
  • Patient wearing a pacemaker.
  • Patients with comorbidities that may increase the risk of perforation.
  • Patient presenting, according to the investigator's judgment, a disease which may prevent participation in the procedures provided for by the study.
  • Patient with an ASA >3. Patient with ASA=3 must be validated by the Principal
  • Investigator (PI).
  • Patient unable to tolerate general anesthesia.
  • Patient with a body mass index (BMI) < 18,5 and > 40.
  • Patient with weight variations >10% between the date on which the CT scan was performed and the date of the procedure.
  • Pregnant or lactating patient.
  • Patient in exclusion period (determined by a previous or a current study).
  • Patient under guardianship or trusteeship.
  • Patient under the protection of justice of deprives of liberty.
  • Patient in situation of emergency

Perprocedure exclusion criteria

• Patient in need of the balloon during the navigation will be excluded of the study (Experimental group)

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Övrig
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: EUS with EZ-EUS navigation system

EUS with the experimental navigation system

Use of the EZ-EUS navigation system during the procedure

Inget ingripande: Standard EUS

EUS in standard condition

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Evaluation of the EUS navigation system's procedure duration compared to standard procedure times
Tidsram: 1 day

Comparison of the examination period duration between the two groups (experimental vs control)

1 day

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Assessment of the EUS navigation system for patient safety
Tidsram: 1 month

Rate of adverse events, adverse device effects and complications

1 month
Assessment of the system's ease-of-use and technological maturity
Tidsram: 1 day

Qualitative assessment of the system's ease-of-use and technological maturity using questionnaires. Appropriate statistical test will be used to compare each procedure. Results will be presented numerically and graphically.

1 day
Assessment of the EUS navigation system for reliability
Tidsram: 1 day

Rate of device deficiencies during the procedure

1 day
Evaluation of the time required to perform individual step duration
Tidsram: 1 day

Comparison of the duration of each individual step

1 day
Recording of procedure data for offline systeme performance assessment
Tidsram: 1 day

Collection and prospective review of EUS data, including video and electromagnetic coordinates provided by the sensor

1 day
Assessment of the registration method
Tidsram: 1 day

Quantitative (numerical) assessment of registration accuracy using Target Registration Error (TRE), defined as the distance between the predicted 3D location of an anatomical landmark by the navigation system and its true 3D location

1 day

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Samarbetspartners

Utredare

  • Huvudutredare: Leonardo SOSA-VALENCIA, MD, IHU Strasbourg, HUS

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

28 januari 2025

Primärt slutförande (Faktisk)

28 januari 2026

Avslutad studie (Faktisk)

28 januari 2026

Studieregistreringsdatum

Först inskickad

21 januari 2025

Först inskickad som uppfyllde QC-kriterierna

27 januari 2025

Första postat (Faktisk)

29 januari 2025

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

17 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

16 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera